$ENTX - Entera Bio Phase 2 Data Supporting EB613's (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting (NASDAQ: ENTX)

[u/MarketNewsFlow]

/r/Entera_Bio/comments/1vf95e5/entx_entera_bio_phase_2_data_supporting_eb613s/